Time to look beyond one-year mortality in critically ill hematological patients?

por Moors, Ine, Benoit, Dominique D
Publicado 2014

A case of chronic eosinophilic leukemia with secondary transformation to acute myeloid leukemia

por Hofmans, Mattias, Delie, Anke, Vandepoele, Karl, Van Roy, Nadine, Van der Meulen, Joni, Philippé, Jan, Moors, Ine
Publicado 2018

P1608: REAL-WORLD INSIGHTS ON THE MANAGEMENT OF IMMUNE-MEDIATED THROMBOTIC THROMBOCYTOPENIC PURPURA (ITTP) WITH CAPLACIZUMAB IN BELGIUM

por Dierickx, Daan, Connerotte, Thierry, Dallemagne, Julie, Becker, Ann De, Moors, Ine, Snauwaert, Sylvia, Sonet, Anne, Theunissen, Koen, Breems, Dimitri, Prijck, Bernard De, Jaspers, Aurélie, Lambert, Catherine, Heyrman, Bert, Hautekiet, Joris, Lyna, Sofie, Maertens, Chantal, Delrieu, Vanessa
Publicado 2023

TARP is an immunotherapeutic target in acute myeloid leukemia expressed in the leukemic stem cell compartment

por Depreter, Barbara, Weening, Karin E., Vandepoele, Karl, Essand, Magnus, De Moerloose, Barbara, Themeli, Maria, Cloos, Jacqueline, Hanekamp, Diana, Moors, Ine, D’hont, Inge, Denys, Barbara, Uyttebroeck, Anne, Van Damme, An, Dedeken, Laurence, Snauwaert, Sylvia, Goetgeluk, Glenn, De Munter, Stijn, Kerre, Tessa, Vandekerckhove, Bart, Lammens, Tim, Philippé, Jan
Publicado 2020

Clinical Impact of Polymerase Chain Reaction–Based Aspergillus and Azole Resistance Detection in Invasive Aspergillosis: A Prospective Multicenter Study

por Huygens, Sammy, Dunbar, Albert, Buil, Jochem B, Klaassen, Corné H W, Verweij, Paul E, van Dijk, Karin, de Jonge, Nick, Janssen, Jeroen J W M, van der Velden, Walter J F M, Biemond, Bart J, Bart, Aldert, Bruns, Anke H W, Haas, Pieter-Jan A, Demandt, Astrid M P, Oudhuis, Guy, von dem Borne, Peter, van der Beek, Martha T, Klein, Saskia K, Godschalk, Peggy, Span, Lambert F R, Postma, Douwe F, Kampinga, Greetje A, Maertens, Johan, Lagrou, Katrien, Mercier, Toine, Moors, Ine, Boelens, Jerina, Selleslag, Dominik, Reynders, Marijke, Zandijk, Willemien, Doorduijn, Jeanette K, Cornelissen, Jan J, Schauwvlieghe, Alexander F A D, Rijnders, Bart J A
Publicado 2023

Inferior Outcome of Addition of the Aminopeptidase Inhibitor Tosedostat to Standard Intensive Treatment for Elderly Patients with AML and High Risk MDS

por Janssen, Jeroen, Löwenberg, Bob, Manz, Markus, Bargetzi, Mario, Biemond, Bart, Borne, Peter von dem, Breems, Dimitri, Brouwer, Rolf, Chalandon, Yves, Deeren, Dries, Efthymiou, Anna, Gjertsen, Bjørn-Tore, Graux, Carlos, Gregor, Michael, Heim, Dominik, Hess, Urs, Hoogendoorn, Mels, Jaspers, Aurelie, Jie, Asiong, Jongen-Lavrencic, Mojca, Klein, Saskia, van der Klift, Marjolein, Kuball, Jürgen, van Lammeren-Venema, Danielle, Legdeur, Marie-Cecile, van de Loosdrecht, Arjan, Maertens, Johan, Kooy, Marinus van Marwijk, Moors, Ine, Nijziel, Marten, van Obbergh, Florence, Oosterveld, Margriet, Pabst, Thomas, van der Poel, Marjolein, Sinnige, Harm, Spertini, Olivier, Terpstra, Wim, Tick, Lidwine, van der Velden, Walter, Vekemans, Marie-Christiane, Vellenga, Edo, de Weerdt, Okke, Westerweel, Peter, Stüssi, Georg, van Norden, Yvette, Ossenkoppele, Gert
Publicado 2021